IM Cannabis (IMCC) EBITDA (2020 - 2026)
IM Cannabis (IMCC) posted quarterly EBITDA of -$1.2 million for Q1 2026, down 1209.91% year-over-year from $110112.8 in Q1 2025, and up 76.47% quarter-over-quarter from -$5.2 million in Q4 2025.
IM Cannabis (IMCC) EBITDA (2020 - 2026) Analysis & Trends
IM Cannabis' EBITDA history runs 7 years deep, the most recent figure standing at -$1.2 million for Q1 2026.
- In Q1 2026, EBITDA fell 1209.91% year-over-year to -$1.2 million; the TTM figure through Mar 2026 stood at -$9.7 million (down 198.39% YoY), while the FY2025 annual figure was -$8.3 million, down 11.16% from the prior year.
- EBITDA for Q1 2026 stood at -$1.2 million, up from -$5.2 million in the prior quarter.
- The five-year high for EBITDA was $7.0 million in Q1 2022, with the low at -$37.5 million in Q4 2022.
- The 5-year median for EBITDA is -$559794.0 (2024), against an average of -$2.8 million.
- The sharpest annual moves came in 2022 and 2026: EBITDA jumped 619.24% in 2022, then sank 1209.91% in 2026.
- IM Cannabis' EBITDA stood at -$37.5 million in 2022, then surged by 59.98% to -$15.0 million in 2023, then surged by 96.27% to -$559794.0 in 2024, then sank by 827.69% to -$5.2 million in 2025, then soared by 76.47% to -$1.2 million in 2026.
- Business Quant data shows IMCC's EBITDA at -$1.2 million in Q1 2026, -$5.2 million in Q4 2025, and -$3.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | IM Cannabis | 537,472.00 | -631,498.17 | 1.09 Mn | -1.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.51 Mn |
| Mar 31, 2026 | -1.22 Mn |
| Dec 31, 2025 | -5.19 Mn |
| Sep 30, 2025 | -3.02 Mn |
| Jun 30, 2025 | -252,599.37 |
| Mar 31, 2025 | 110,112.80 |
| Dec 31, 2024 | -559,794.03 |
| Sep 30, 2024 | -698,599.90 |
| Jun 30, 2024 | -2.10 Mn |
| Mar 31, 2024 | -4.18 Mn |
| Dec 31, 2023 | -15.00 Mn |
| Sep 30, 2023 | 1.69 Mn |
| Jun 30, 2023 | 1.30 Mn |
| Mar 31, 2023 | 2.68 Mn |
| Dec 31, 2022 | -37.48 Mn |
| Sep 30, 2022 | 4.24 Mn |
| Jun 30, 2022 | 4.41 Mn |
| Mar 31, 2022 | 6.99 Mn |
| Dec 31, 2021 | -8.46 Mn |
| Sep 30, 2021 | -4.86 Mn |